Replies to post #136369 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

I have always felt 273 was the stepping stone to 371 "the super 273"..we have the patent and the science behind it

AND, we can see how the new FDA will spend lots of time "assessing" new NDA/IND/trial cycles. Gottlieb is raising the BAR way up in real time...(see his CNBC interview posted earlier today)... BACK AT YA... It all fits, new sheriff on watch and AVXL are right in the middle of it. Bottom line is, lots of emphasis on prep/science/computer models/analysis. Some might suggest to Dr. M., be careful of what you ask for...you just might get it. t Instincts say ,that is what is going on, w/o a doubt. Let's see if BP can walk and chew gum, b/c they cannot have it both ways like the old days.

IMO, FDA has said...prove you have done your homework before we even discuss PIII trials.